溶酶体不稳定:病理性化和骨关节炎之间缺失的联系
Tao Ye1, Chenyu Wang1, Jianfei Yan2
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration & National Clinical Research Center for Oral Diseases & Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, PR China.
骨关节炎软骨中的酸酸会导致冠状细胞细胞死亡. 抑制 lysosomal 膜通透和 cathepsin B 阻止了这种细胞死亡,为骨关节炎提供了一个新的治疗策略.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 类风湿病学 类风湿病学
背景情况:
- 软骨中酸沉积是骨关节炎 (OA) 的一个关键特征,与疾病严重程度相关.
- 目前缺乏防止酸沉积在OA软骨中的策略.
- 酸在OA病变发生过程中的确切作用仍在争论中.
研究的目的:
- 为了阐明在骨关节炎中内软骨性酸酸的致病机制.
- 制定策略,以抵消氧化沉积在OA中的酸沉积的有害影响.
主要方法:
- 使用了骨关节炎的体外和体内模型.
- 研究了细胞吸收和处理酸晶体的过程.
- 评估了溶酶体膜通透 (LMP) 和甲素B (CTSB) 释放的作用.
- 检查了NLRP3炎症酶的激活和随后的冠状细胞灭.
主要成果:
- 氧酸盐结晶体是由细胞细胞化并在溶酶体内进行处理.
- 这种处理导致 lysosomal 膜通透 (LMP) 和 cathepsin B (CTSB) 释放到细胞质中.
- 细胞质CTSB激活了NLRP3炎症体,触发了状细胞灭.
- 在体内抑制LMP和CTSB有效地控制了骨关节炎的进展.
结论:
- 氧酸盐诱导的溶酶体不稳定和甲素B的释放驱动骨关节炎中的冠状细胞灭.
- 向 lysosomal 膜通透和 cathepsin B 呈现出一种可行的治疗方法来治疗关节炎.
- 缓解 lysosomal 不稳定提供了一个概念解决方案,以防止骨关节炎的进展.
更多相关视频
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
相关概念视频
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Lysosomal Hydrolases
Bone Remodeling
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
